PubMed:17293353 / 327-727 JSONTXT

{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":106,"end":111},"obj":"http://purl.obolibrary.org/obo/MAT_0000098"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":400},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":400},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":400},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":167,"end":169},"obj":"http://www.uniprot.org/uniprot/Q99707"},{"id":"T5","span":{"begin":213,"end":216},"obj":"http://www.uniprot.org/uniprot/P19957"},{"id":"T6","span":{"begin":285,"end":288},"obj":"http://www.uniprot.org/uniprot/P19957"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":167,"end":169},"obj":"http://www.uniprot.org/uniprot/A6H5Y3"},{"id":"T5","span":{"begin":275,"end":279},"obj":"http://www.uniprot.org/uniprot/Q9WUD1"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T1","span":{"begin":112,"end":118},"obj":"http://purl.bioontology.org/ontology/STY/T024"},{"id":"T2","span":{"begin":189,"end":193},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/490857"},{"id":"T3","span":{"begin":208,"end":212},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/490857"},{"id":"T4","span":{"begin":280,"end":284},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/490857"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"GO-BP","denotations":[{"id":"T1","span":{"begin":138,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0032502"},{"id":"T2","span":{"begin":308,"end":314},"obj":"http://purl.obolibrary.org/obo/GO_0060361"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"UBERON-AE","denotations":[{"id":"T1","span":{"begin":106,"end":111},"obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"T4","span":{"begin":112,"end":118},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"GlycoBiology-MAT","denotations":[{"id":"T1","span":{"begin":106,"end":111},"obj":"http://purl.obolibrary.org/obo/MAT_0000098"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":106,"end":111},"obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"PD-UBERON-AE-B_T4","span":{"begin":112,"end":118},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"mondo_disease","denotations":[{"id":"T4","span":{"begin":80,"end":91},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0016681"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T4","span":{"begin":80,"end":91},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0016681"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"GlyCosmos15-NCBITAXON","denotations":[{"id":"T2","span":{"begin":74,"end":79},"obj":"OrganismTaxon"}],"attributes":[{"id":"A2","pred":"db_id","subj":"T2","obj":"9606"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T1","span":{"begin":106,"end":111},"obj":"Body_part"},{"id":"T3","span":{"begin":112,"end":118},"obj":"Body_part"},{"id":"T4","span":{"begin":344,"end":349},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"A2","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_6110636"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000119"},{"id":"A5","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0022303"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"GlyCosmos15-MAT","denotations":[{"id":"T1","span":{"begin":106,"end":111},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000098"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":400},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":400},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":400},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T3","span":{"begin":0,"end":400},"obj":"Sentence"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"NCBITAXON","denotations":[{"id":"T2","span":{"begin":74,"end":79},"obj":"OrganismTaxon"}],"attributes":[{"id":"A2","pred":"db_id","subj":"T2","obj":"9606"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":106,"end":111},"obj":"Body_part"},{"id":"T3","span":{"begin":112,"end":118},"obj":"Body_part"},{"id":"T4","span":{"begin":344,"end":349},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"A2","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_6110636"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000119"},{"id":"A5","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0022303"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}

{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":106,"end":111},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000098"}],"text":"Here, we describe the first systematic GG composition characterization in human gliosarcoma versus normal brain tissue using our recently developed mass spectrometry (MS) methods, based on nano-electrospray (nano-ESI), Fourier-transform ion cyclotron resonance (FT-ICR), and chip nano-ESI quadrupole time-of-flight (QTOF), complemented by thin-layer chromatographic (TLC) analysis and quantification."}